Slate Medicines
Advancing next-generation therapeutics for migraine and other headache disorders
$130MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Advancing next-generation therapeutics for migraine and other headache disorders
Develops treatments for chronic lung diseases, focusing on viral respiratory infections